|
10 Dec 2025 |
Cyient
|
Consensus Share Price Target
|
1131.60 |
1271.48 |
- |
12.36 |
hold
|
|
|
|
|
10 May 2024
|
Cyient
|
Geojit BNP Paribas
|
1131.60
|
1972.00
|
1721.65
(-34.27%)
|
Target met |
Accumulate
|
|
|
|
|
26 Apr 2024
|
Cyient
|
IDBI Capital
|
1131.60
|
2210.00
|
1885.80
(-39.99%)
|
|
Buy
|
|
|
|
|
26 Apr 2024
|
Cyient
|
Axis Direct
|
1131.60
|
2500.00
|
1885.80
(-39.99%)
|
|
Buy
|
|
|
With strong growth potential backed by robust deal wins and superior execution capabilities, we maintain our BUY recommendation on the stock.
|
|
26 Apr 2024
|
Cyient
|
Emkay
|
1131.60
|
2600.00
|
1885.80
(-39.99%)
|
|
Buy
|
|
|
Cyient reported a weak operating performance in Q4FY24. DET revenue grew 0.1% QoQ (decline of 0.5% cc), falling short of our estimate of 1.4% QoQ growth.
|
|
10 Feb 2024
|
Cyient
|
Axis Direct
|
1131.60
|
2460.00
|
2192.25
(-48.38%)
|
|
Buy
|
|
|
We recommend a BUY rating on the stock with a near term TP of Rs 2460, implying an upside of 12% from CMP.
|
|
05 Feb 2024
|
Cyient
|
Geojit BNP Paribas
|
1131.60
|
2447.00
|
2169.45
(-47.84%)
|
|
Accumulate
|
|
|
|
|
29 Jan 2024
|
Cyient
|
Axis Direct
|
1131.60
|
3000.00
|
2006.45
(-43.60%)
|
|
Buy
|
|
|
With strong growth potential backed by robust deal wins and superior execution capabilities, we maintain our BUY recommendation on the stock.
|
|
28 Jan 2024
|
Cyient
|
IDBI Capital
|
1131.60
|
2360.00
|
2019.65
(-43.97%)
|
|
Buy
|
|
|
|
|
11 Dec 2023
|
Cyient
|
Axis Direct
|
1131.60
|
2195.00
|
2003.45
(-43.52%)
|
Target met |
Buy
|
|
|
We recommend a BUY rating on the stock and assign a 22x P/E multiple to its FY26E earnings of Rs 99.4/share to arrive at a TP of Rs 2,195/share, implying an upside of 13% from the CMP.
|
|
09 Dec 2023
|
Cyient
|
Motilal Oswal
|
1131.60
|
2250.00
|
1949.85
(-41.96%)
|
Target met |
Buy
|
|
|
|